4.4 Review

Review of current and future therapeutics in ABPA

Related references

Note: Only part of the references are listed.
Article Allergy

New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation

Koichiro Asano et al.

Summary: The study proposed new diagnostic criteria for ABPA/ABPM, which showed better sensitivity and specificity compared to existing methods.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Allergy

Which Are the Optimal Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis? A Latent Class Analysis

Puneet Saxena et al.

Summary: This study compared the diagnostic performance of various criteria for evaluating ABPA and found that optimal diagnostic performance could be achieved by modifying the existing ISHAM criteria, with increased cost. The ISHAM-ABPA Working Group criteria were only marginally better than the Patterson criteria in diagnosing ABPA among patients with asthma younger than 66 years.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Medicine, Research & Experimental

STING activation in alveolar macrophages and group 2 innate lymphoid cells suppresses IL-33-driven type 2 immunopathology

Li She et al.

Summary: 2'3'-cGAMP activates the STING pathway to negatively regulate type 2 immune responses, attenuating lung immunopathology induced by IL-33 and a fungal allergen. This molecule is mainly internalized by alveolar macrophages, activating the STING/IRF3/IFN pathway to inhibit IL-33-mediated activation of ILC2 cells.

JCI INSIGHT (2021)

Article Allergy

Real-World Effectiveness of AntieIL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal Sensitization

Jaideep Dhariwal et al.

Summary: Treatment with eosinophil-targeting biologics led to improvements in exacerbation frequency, oral corticosteroid requirements, and patient-reported outcomes in patients with SAFS, with a reduction in exacerbations in the subgroup of patients with ABPA. These data highlight the potential clinical utility of targeting eosinophilic inflammation in SAFS and ABPA.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Review Allergy

Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s

Kathleen R. Bartemes et al.

Summary: ILC2, a type of innate lymphoid cell, responds rapidly to allergen exposure and environmental insults in mucosal organs by producing type 2 cytokines. In addition to being activated by epithelium-derived cytokines, ILC2s are regulated by other cytokines, eicosanoids, and neuropeptides.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Infectious Diseases

Ibrexafungerp: A novel oral glucan synthase inhibitor

M. R. Davis et al.

MEDICAL MYCOLOGY (2020)

Article Respiratory System

Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis

Angela Koutsokera et al.

JOURNAL OF CYSTIC FIBROSIS (2020)

Article Allergy

Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?

Carlo Muemmler et al.

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2020)

Review Microbiology

Review of the Novel Investigational Antifungal Olorofim

Nathan P. Wiederhold

JOURNAL OF FUNGI (2020)

Review Immunology

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy

Max E. Kirtland et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Allergic bronchopulmonary aspergillosis

Ritesh Agarwal et al.

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Article Respiratory System

Investigating the effects of long-term dornase alfa use on lung function using registry data

S. J. Newsome et al.

JOURNAL OF CYSTIC FIBROSIS (2019)

Review Infectious Diseases

Pathophysiological aspects of Aspergillus colonization in disease

Sara Gago et al.

MEDICAL MYCOLOGY (2019)

Article Infectious Diseases

Posaconazole for the treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

J. Periselneris et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Article Pharmacology & Pharmacy

Mucosal IgE immune responses in respiratory diseases

Ibon Eguiluz-Gracia et al.

CURRENT OPINION IN PHARMACOLOGY (2019)

Article Medicine, General & Internal

Treatment of allergic bronchopulmonary mycosis: Experience of 55 patients with 124 relapses-A descriptive study

Takashi Ishiguro et al.

CLINICAL CASE REPORTS (2019)

Article Allergy

Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus

Valdirene S. Muniz et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Review Infectious Diseases

Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy

Amelia K. Sofjan et al.

JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2018)

Review Immunology

Eosinophil Extracellular Traps and Inflammatory Pathologies-Untangling the Web!

Manali Mukherjee et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Infectious Diseases

Estimating the burden of invasive and serious fungal disease in the United Kingdom

Matthew Pegorie et al.

JOURNAL OF INFECTION (2017)

Article Biochemistry & Molecular Biology

Role of Aspergillus fumigatus in Triggering Protease-Activated Receptor-2 in Airway Epithelial Cells and Skewing the Cells toward a T-helper 2 Bias

Tetsuya Homma et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)

Review Microbiology

First Line of Defense: Innate Cell-Mediated Control of Pulmonary Aspergillosis

Vanessa Espinosa et al.

FRONTIERS IN MICROBIOLOGY (2016)

Review Microbiology

Allergic Bronchopulmonary Aspergillosis

Michael C. Tracy et al.

JOURNAL OF FUNGI (2016)

Article Allergy

Genetic susceptibility to allergic bronchopulmonary aspergillosis in asthma: a genetic association study

Nicola L. D. Overton et al.

ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2016)

Article Biochemistry & Molecular Biology

Suppression of Epithelial Signal Transducer and Activator of Transcription 1 Activation by Extracts of Aspergillus fumigatus

Bharat Bhushan et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)

Article Cardiac & Cardiovascular Systems

Development of chronic pulmonary aspergillosis in adult asthmatics with ABPA

David Lowes et al.

RESPIRATORY MEDICINE (2015)

Article Allergy

Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis

Astrid L. Voskamp et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)

Review Respiratory System

The clinical spectrum of pulmonary aspergillosis

Chris Kosmidis et al.

THORAX (2015)

Review Microbiology

The innate immune response to Aspergillus fumigatus at the alveolar surface

Anatte Margalit et al.

FEMS MICROBIOLOGY REVIEWS (2015)

Article Multidisciplinary Sciences

Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis

Joanne Armstead et al.

PLOS ONE (2014)

Letter Respiratory System

Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations

Inderpaul Singh Sehgal et al.

EUROPEAN RESPIRATORY REVIEW (2014)

Review Immunology

T Cell-Mediated Host Immune Defenses in the Lung

Kong Chen et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)

Article Genetics & Heredity

Mannose-binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis

E. Harrison et al.

INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2012)

Article Nanoscience & Nanotechnology

New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis

Christophe Duret et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)

Article Cardiac & Cardiovascular Systems

Serologic allergic bronchopulmonary aspergillosis (ABPA-S): Long-term outcomes

Ritesh Agarwal et al.

RESPIRATORY MEDICINE (2012)

Review Immunology

Allergic Bronchopulmonary Aspergillosis in Asthma and Cystic Fibrosis

Alan P. Knutsen et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2011)

Article Respiratory System

Sequential Bronchoscopy in the Management of Lobar Atelectasis Secondary to Allergic Bronchopulmonary Aspergillosis

Paul Whitaker et al.

JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

High attenuation mucoid impaction in allergic bronchopulmonary aspergillosis

Ritesh Agarwal

WORLD JOURNAL OF RADIOLOGY (2010)

Review Respiratory System

A Review on the Clinical Use of Inhaled Amphotericin B

Laura Kuiper et al.

JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2009)

Article Respiratory System

Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis

Malena Cohen-Cymberknoh et al.

JOURNAL OF CYSTIC FIBROSIS (2009)

Article Multidisciplinary Sciences

High diversity of fungi in air particulate matter

Janine Froehlich-Nowoisky et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Immunology

Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis

A. Carvalho et al.

JOURNAL OF INFECTIOUS DISEASES (2008)

Article Infectious Diseases

Th1/Th2 in aspergillosis

David A. Stevens

MEDICAL MYCOLOGY (2006)

Article Immunology

Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages

O Ibrahim-Granet et al.

INFECTION AND IMMUNITY (2003)

Article Biochemistry & Molecular Biology

Immunopathogenesis of allergic bronchopulmonary aspergillosis and airway remodeling

HF Kauffman

FRONTIERS IN BIOSCIENCE-LANDMARK (2003)

Article Critical Care Medicine

Mast cell tryptases and airway remodeling

CP Sommerhoff

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)

Article Immunology

Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes

RB Moss et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)

Article Medicine, General & Internal

A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.

DA Stevens et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)